About

Hilary Baker is a leading urologic surgeon whose research focuses on advancing surgical outcomes for bladder cancer patients through minimally invasive techniques and enhanced recovery protocols. Her work centers on robot-assisted radical cystectomy with intracorporeal urinary diversion (iRARC), demonstrating how this approach—combined with structured recovery programs—can significantly improve postoperative outcomes. Baker’s most-cited study (76 citations) showed that integrating iRARC with an enhanced recovery after surgery (ERAS) pathway reduces hospital stays and complications compared to open surgery, a concept she terms “aggregating marginal gains.” She further proved that iRARC benefits even patients with low cardiorespiratory fitness, expanding surgical access to higher-risk populations. Her prospective work on health-related quality of life (23 citations) identified key factors influencing recovery, while her analysis of blood transfusion requirements (19 citations) clarified perioperative risk factors. During the COVID-19 pandemic, Baker helped design safe cystectomy protocols for high-volume centers. Her cumulative research has redefined standards for bladder cancer surgery, emphasizing that technological innovation and systematic care pathways together yield the best patient outcomes.

Research Focus

Key Achievements

5
H-Index
7
Papers
159
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
Intracorporeal robot‐assisted radical cystectomy, together with an enhanced recovery programme, improves postoperative outcomes by aggregating marginal gains
76 citations · 2017
📈 Most Prolific Year: 2017 (3 Papers)
🤝 Key Collaborators: 41
🏛 Institutions: University College Hospital, University College London, University College London Hospitals NHS Foundation Trust, University College Hospital at Westmoreland Street

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago